title: Neurocysticercosis: Five new things.
abstract: Neurocysticercosis is the most common parasitic brain disease worldwide. Its clinical heterogeneity is related to localization, number and stage of evolution of the parasites, sex, age, and intensity of the host brain inflammatory reaction. In addition to the localization of the parasite, inflammation is the main phenomenon responsible of symptomatology. Acute symptomatic seizures are the most common symptom in patients with parenchymal parasites, but most do not evolve into epilepsy. Neurocysticercosis diagnosis is based mainly on neuroimaging. New imaging techniques have improved detection of the scolex and visualization of cysts in the extraparenchymal spaces. Immunologic testing can be useful, particularly when imaging is equivocal. Based on disappearance of parasites, antihelminthic drugs as currently used are effective in approximately one-third of patients with parenchymal viable cysts.
authors.affiliation: Research Department (AC), University of Cuenca, Cuenca, Ecuador; G.H. Sergievsky Center (AC, WAH), Faculty of Medicine, Columbia University, New York, NY; and Instituto de Investigaciones Biomédicas (AF), UNAM Instituto Nacional de Neurologia y Neurocirugía, SS, Mexico City, Mexico.
authors.forename: Arturo
authors.initials: A
authors.lastname: Carpio
authors.forename: Agnès
authors.initials: A
authors.lastname: Fleury
authors.forename: W Allen
authors.initials: WA
authors.lastname: Hauser
references.citation: Eur Arch Psychiatry Clin Neurosci. 2006 Aug;256(5):307-10
references.pmid: 16816897
references.citation: Ann Intern Med. 2006 Jul 4;145(1):43-51
references.pmid: 16818928
references.citation: Cent Nerv Syst Agents Med Chem. 2011 Dec 1;11(4):261-84
references.pmid: 22300228
references.citation: Neurology. 2012 Feb 28;78(9):618-25
references.pmid: 22302547
references.citation: Parasitol Int. 2006;55 Suppl:S127-30
references.pmid: 16337432
references.citation: Ann Trop Med Parasitol. 2009 Sep;103(6):487-99
references.pmid: 19695154
references.citation: Infect Immun. 2011 Jul;79(7):2586-96
references.pmid: 21482681
references.citation: J Neurol Neurosurg Psychiatry. 2008 Sep;79(9):1050-5
references.pmid: 18495737
references.citation: Expert Rev Anti Infect Ther. 2011 Jan;9(1):123-33
references.pmid: 21171883
references.citation: Cochrane Database Syst Rev. 2010 Mar 17;(3):CD000215
references.pmid: 20238309
references.citation: J Parasitol. 2012 Feb;98(1):142-8
references.pmid: 21955298
references.citation: Neurology. 2001 Jul 24;57(2):177-83
references.pmid: 11480424
references.citation: Lancet Infect Dis. 2002 Dec;2(12):751-62
references.pmid: 12467692
references.citation: Trans R Soc Trop Med Hyg. 2010 Apr;104(4):243-50
references.pmid: 20116079
references.citation: Vet Parasitol. 2010 Feb 26;168(1-2):130-5
references.pmid: 19963321
references.citation: J Infect Dis. 2010 Oct 15;202(8):1219-25
references.pmid: 20807077
references.citation: Lancet Neurol. 2008 Dec;7(12):1099-105
references.pmid: 18986841
references.citation: Epilepsia. 2010 Apr;51(4):671-5
references.pmid: 19732133
references.citation: Neurology. 2010 Dec 14;75(24):2236-45
references.pmid: 21172847
references.citation: N Engl J Med. 2004 Jan 15;350(3):249-58
references.pmid: 14724304